Bristol Myers Squibb will get final approval of its antitrust settlement with a class of direct purchasers of HIV drugs, the California federal judge overseeing the litigation said today.The litigation against Gilead, Bristol Myers Squibb, Janssen Pharmaceuticals, Johnson & Johnson, and Teva Pharmaceuticals alleges a conspiracy to block generic drugs used to